The improved accessibility to resources that can aid in understanding the disease mechanisms is estimated to spur the Central Nervous System Biomarkers Market Size. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. The market is predicted to be motivated by a 13.0% CAGR leading to revenues worth USD 7,500 million by 2027. The augmented use in diagnosing neurodegenerative diseases is foreseen to transform the central nervous system biomarkers market in the forecast period. The improved facilities available for research are estimated to accelerate further the overall development of the Central Nervous System Biomarkers Market Growth, share in the course of the forecast period.